← Stack Research Tool

Pair page

HCG with HGH

Mechanism-tag overlap and published literature for HCG and HGH, pulled verbatim from each Kalios compound profile. Kalios is a literature reference, not a recommendation.

Mechanism overlap

Mechanism tags are verbatim labels on each compound's profile. Generic tags ("peptide", "small-molecule", "research-chemical") are excluded from this overlap view. Tags are descriptive — not an inference about combined effect.

HCG HGH 2 UNIQUE TAGS 2 UNIQUE TAGS 1 SHARED
HCG unique glycoprotein-gonadotropinlh-analog
Shared hormone
HGH unique recombinant-human-growth-hormonerhgh

Quick facts

HCG

RouteSubQ / IM
Half-life~24–36 hours (biological)
FDA statusApproved (hypogonadism, cryptorchidism, infertility)
WADABanned in males (S2)
Full HCG profile →

HGH

RouteSubQ (daily); IM (less common)
Half-life~2–3 hours (SubQ); biological effect ~24 h
FDA statusApproved (GHD, Turner, PWS, SHOX, ISS, CKD, AIDS wasting, S…
WADABanned (S2) at all times
Full HGH profile →

Literature table

Classified references from each compound profile. Click a column header to sort. Click a PMID to open PubMed. Findings are quoted verbatim from each profile's literature_summary; nothing here is added or interpreted.

Year Compound Source Finding
2014HCGRastrelli G, Corona G, Mannucci E, Maggi M. Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology. 2014;2(6):794-808. PMID: 25099686. (Meta-analysis of spermatogenesis response to gonadotropin replacement — relevant to hCG/FSH… PMID 25099686meta-analysis
2018HCGBhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID: 29562364. (Soc… PMID 29562364human study
2013HCGHsieh TC, Pastuszak AW, Hwang K, Lipshultz LI. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013;189(2):647-650. PMID: 23260550. PMID 23260550human study
2013HCGKaminetsky J, Werner M, Fontenot G, Wiehle RD. Oral enclomiphene citrate stimulates the endogenous production of testosterone and sperm counts in men with low testosterone: comparison with testosterone gel. J Sex Med. 2013;10(6):1628-1635. PMID: 23530575. (Adjacent SERM-based ax… PMID 23530575human study
2026HCGWADA. 2026 World Anti-Doping Code Prohibited List. Section S2 — Peptide hormones, growth factors, related substances, and mimetics. World Anti-Doping Agency. (hCG specifically prohibited in males.)regulatory / registry
2000HCGU.S. Food and Drug Administration. Ovidrel (choriogonadotropin alfa) Prescribing Information. EMD Serono. First approved 2000.regulatory / registry
HCGU.S. Food and Drug Administration. Pregnyl (chorionic gonadotropin) Prescribing Information. Organon USA Inc.regulatory / registry
HCGU.S. Food and Drug Administration. Novarel (chorionic gonadotropin) Prescribing Information. Ferring Pharmaceuticals.regulatory / registry
2018HCGLee JA, Ramasamy R. Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men. Transl Androl Urol. 2018;7(Suppl 3):S348-S352. PMID: 30050800. PMID 30050800research article
2017HCGShiraishi K, Matsuyama H. Gonadotoropin actions on spermatogenesis and hormonal therapies for spermatogenic disorders. Endocr J. 2017;64(2):123-131. PMID: 28100858. PMID 28100858research article
2015HCGRamasamy R, Armstrong JM, Lipshultz LI. Preserving fertility in the hypogonadal patient: an update. Asian J Androl. 2015;17(2):197-200. PMID: 25652635. PMID 25652635research article
2013HCGCrosnoe LE, Grober E, Ohl D, Kim ED. Exogenous testosterone: a preventable cause of male infertility. Transl Androl Urol. 2013;2(2):106-113. PMID: 26813847. (Mechanism and clinical framing of TRT-induced infertility and hCG-based prevention.) PMID 26813847research article
2007HGHLiu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, Hoffman AR. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007;146(2):104-115. PMID: 17200260. (The most-cited independent appraisal of anti-aging rhGH.) PMID 17200260systematic review
2020HGHJohannsson G, Gordon MB, Højby Rasmussen M, Håkonsson IH, Karges W, Sværke C, Tahara S, Takano K, Biller BMK. Once-weekly somapacitan is effective and well tolerated in adults with GH deficiency: a randomized phase 3 trial. J Clin Endocrinol Metab. 2020;105(4):e1358-e1376. PMID:… PMID 32072187human trial, Phase 3
2000HGHMauras N, Attie KM, Reiter EO, Saenger P, Baptista J; Genentech, Inc Cooperative Study Group. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. J Clin Endocrinol Metab. 2000… PMID 11061517human trial
2012HGHSävendahl L, Maes M, Albertsson-Wikland K, Borgström B, Carel JC, Henrard S, Speybroeck N, Thomas M, Zandwijken G, Hokken-Koelega A. Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium… PMID 22259051human study
2011HGHMolitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML; Endocrine Society. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(6):1587-1609. PMID: 21543432. PMID 21543432human study
2003HGHGrinspoon S, Mulligan K; Department of Health and Human Services Working Group on the Prevention and Treatment of Wasting and Weight Loss. Weight loss and wasting in patients infected with human immunodeficiency virus. Clin Infect Dis. 2003;36(Suppl 2):S69-S78. PMID: 12652374. (… PMID 12652374human study
1990HGHRudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990;323(1):1-6. PMID: 2355952. (The landmark anti-aging reference.) PMID 2355952human study
2026HGHWADA. 2026 World Anti-Doping Code Prohibited List. Section S2 — Peptide hormones, growth factors, related substances and mimetics. World Anti-Doping Agency. (rhGH S2 prohibition and detection methods.)regulatory / registry
2021HGHU.S. Food and Drug Administration. Skytrofa (lonapegsomatropin-tcgd) Prescribing Information. Ascendis Pharma. First approved 2021.regulatory / registry
2020HGHU.S. Food and Drug Administration. Sogroya (somapacitan) Prescribing Information. Novo Nordisk. First approved 2020.regulatory / registry
HGHU.S. Food and Drug Administration. Genotropin (somatropin) Prescribing Information. Pfizer Inc.regulatory / registry
HGHU.S. Food and Drug Administration. Norditropin (somatropin) Prescribing Information. Novo Nordisk Inc.regulatory / registry

Related pair pages

More research context

Frequently asked

Have HCG and HGH been studied together?

No co-administration studies between HCG and HGH are catalogued on Kalios. The pair page lists only the individual published literature for each compound and any shared mechanism tags.

What mechanisms do HCG and HGH share?

HCG and HGH share these mechanism tags on their Kalios profiles: hormone. Tags are descriptive and verbatim from each compound profile — not an inference of combined effect.

What is the FDA status of HCG and HGH?

HCG: Approved (hypogonadism, cryptorchidism, infertility). HGH: Approved (GHD, Turner, PWS, SHOX, ISS, CKD, AIDS wasting, SBS). FDA-status text is pulled verbatim from each compound profile. See /fda-pcac-2026.html for the broader FDA Pharmacy Compounding Advisory Committee context.

Where can I find the full research on HCG and HGH?

Full citation lists, dosing tables from the literature, reconstitution data, and the FDA / WADA status are on the individual compound profiles: the HCG profile and the HGH profile. The Kalios Stack Research Tool hub lists every compound covered.

Last updated: April 2026